AAAAAA
Results:
1-15
|
Results: 15
Authors:
Cleland, JL
Daugherty, A
Mrsny, R
Citation: Jl. Cleland et al., Emerging protein delivery methods, CURR OPIN B, 12(2), 2001, pp. 212-219
Authors:
Duenas, ET
Keck, R
De Vos, A
Jones, AJS
Cleland, JL
Citation: Et. Duenas et al., Comparison between light induced and chemically induced oxidation of rhVEGF, PHARM RES, 18(10), 2001, pp. 1455-1460
Authors:
Cleland, JL
Duenas, ET
Park, A
Daugherty, A
Kahn, J
Kowalski, J
Cuthbertson, A
Citation: Jl. Cleland et al., Development of poly-(D,L-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis, J CONTR REL, 72(1-3), 2001, pp. 13-24
Authors:
Webb, JN
Webb, SD
Cleland, JL
Carpenter, JF
Randolph, TW
Citation: Jn. Webb et al., Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High-pressure and cosolute studies on recombinant human IFN-gamma, P NAS US, 98(13), 2001, pp. 7259-7264
Authors:
Lam, XM
Duenas, ET
Cleland, JL
Citation: Xm. Lam et al., Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres, J PHARM SCI, 90(9), 2001, pp. 1356-1365
Authors:
Cleland, JL
Lam, X
Kendrick, B
Yang, J
Yang, TH
Overcashier, D
Brooks, D
Hsu, C
Carpenter, JF
Citation: Jl. Cleland et al., A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody, J PHARM SCI, 90(3), 2001, pp. 310-321
Authors:
Hovorka, SW
Hong, JY
Cleland, JL
Schoneich, C
Citation: Sw. Hovorka et al., Metal-catalyzed oxidation of human growth hormone: Modulation by solvent-induced changes of protein conformation, J PHARM SCI, 90(1), 2001, pp. 58-69
Authors:
Lam, XM
Duenas, ET
Daugherty, AL
Levin, N
Cleland, JL
Citation: Xm. Lam et al., Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes, J CONTR REL, 67(2-3), 2000, pp. 281-292
Authors:
Goolcharran, C
Stauffer, LL
Cleland, JL
Borchardt, RT
Citation: C. Goolcharran et al., The effects of a histidine residue on the c-terminal side of an asparaginyl residue on the rate of deamidation using model pentapeptides, J PHARM SCI, 89(6), 2000, pp. 818-825
Authors:
Yang, TH
Cleland, JL
Lam, X
Meyer, JD
Jones, LS
Randolph, TW
Manning, MC
Carpenter, JF
Citation: Th. Yang et al., Effect of zinc binding and precipitation on structures of recombinant human growth hormone and nerve growth factor, J PHARM SCI, 89(11), 2000, pp. 1480-1485
Authors:
Saltzman, WM
Mak, MW
Mahoney, MJ
Duenas, ET
Cleland, JL
Citation: Wm. Saltzman et al., Intracranial delivery of recombinant nerve growth factor: Release kineticsand protein distribution for three delivery systems, PHARM RES, 16(2), 1999, pp. 232-240
Authors:
Cleland, JL
Citation: Jl. Cleland, Single-administration vaccines: controlled-release technology to mimic repeated immunizations, TRENDS BIOT, 17(1), 1999, pp. 25-29
Authors:
Yang, TH
Dong, AC
Meyer, J
Johnson, OL
Cleland, JL
Carpenter, JF
Citation: Th. Yang et al., Use of infrared spectroscopy to assess secondary structure of human growthhormone within biodegradable microspheres, J PHARM SCI, 88(2), 1999, pp. 161-165
Authors:
Cleland, JL
Lim, A
Daugherty, A
Barron, L
Desjardin, N
Duenas, ET
Eastman, DJ
Vennari, JC
Wrin, T
Berman, P
Murthy, KK
Powell, MF
Citation: Jl. Cleland et al., Development of a single-shot subunit vaccine for HIV-1. 5. Programmable invivo autoboost and long lasting neutralizing response, J PHARM SCI, 87(12), 1998, pp. 1489-1495
Authors:
Bam, NB
Cleland, JL
Yang, J
Manning, MC
Carpenter, JF
Kelley, RF
Randolph, JW
Citation: Nb. Bam et al., Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions, J PHARM SCI, 87(12), 1998, pp. 1554-1559
Risultati:
1-15
|